Weller Michael, Butowski Nicholas, Tran David D., Recht Lawrence D., Lim Michael, Hirte Hal, . . . Hideghéty Katalin. (2017). Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): A randomised, double-blind, international phase 3 trial.
Chicago Style (17th ed.) CitationWeller Michael, et al. Rindopepimut with Temozolomide for Patients with Newly Diagnosed, EGFRvIII-expressing Glioblastoma (ACT IV): A Randomised, Double-blind, International Phase 3 Trial. 2017.
MLA idézésWeller Michael, et al. Rindopepimut with Temozolomide for Patients with Newly Diagnosed, EGFRvIII-expressing Glioblastoma (ACT IV): A Randomised, Double-blind, International Phase 3 Trial. 2017.
Figyelem: ezek az hivatkozások nem 100%-ban pontosak..